Oncology Medical Billing Services in San Antonio
San Antonio’s oncology billing environment is anchored by three intersecting complexities that distinguish it from most Texas markets: the UT Health San Antonio Mays Cancer Center generates significant clinical trial billing that must satisfy both NCI Cooperative Group protocols and commercial payer clinical trial coverage policies simultaneously; Bexar County’s large active-duty and veteran military population creates heavy TRICARE oncology authorization demands for chemotherapy, radiation, and surgical oncology services; and the region’s predominantly Hispanic/Latino demographics drive elevated rates of cervical, colorectal, liver, and gallbladder cancers — each with distinct ICD-10 coding patterns and TMHP Medicaid prior authorization requirements. MedVoice delivers expert oncology billing solutions in San Antonio, supporting medical oncology practices, radiation oncology centers, surgical oncology groups, TRICARE-contracted clinics, and infusion therapy providers throughout Bexar County.
Proven Performance, Tangible Results
These results reflect MedVoice’s billing performance across San Antonio’s oncology payer mix — TRICARE, TMHP Medicaid, Medicare, and commercial plans — including high-value chemotherapy infusion, radiation oncology, and clinical trial service lines.
98%
Clean Claim Rate
San Antonio oncology claims — including TRICARE chemotherapy authorizations, TMHP J-code submissions, and clinical trial billing — pass payer edits at a 98% first-pass rate through oncology-specific pre-submission scrubbing.
40%
Reduction in A/R Days
Dedicated follow-up on TRICARE chemotherapy authorization disputes, TMHP drug coverage denials, and radiation oncology global period claims reduces outstanding A/R by 40% for San Antonio oncology practices.
98%
Coding Accuracy
Certified oncology coders achieve 98% accuracy on chemotherapy administration CPT codes, anti-cancer drug J-codes, and radiation oncology fraction billing — eliminating the selection errors most common in San Antonio's TRICARE and TMHP oncology claims.
15%
Increase in Revenue Collection
TRICARE fee schedule optimization, TMHP drug coverage accuracy, J-code reimbursement maximization, and denial recovery on high-value infusion claims generate a 15% increase in net collections for San Antonio oncology practices.
Challenges We Solve for Oncology Practices in San Antonio
Oncology billing in San Antonio operates across payer types that each impose distinct authorization and coverage requirements on the same chemotherapy, radiation, and surgical oncology services. TRICARE’s Defense Health Agency prior authorization process for antineoplastic therapy differs materially from TMHP’s oncology drug coverage policies and commercial plans’ step-therapy requirements. Expert oncology denial management that addresses San Antonio’s specific payer environment is essential for protecting revenue on high-cost cancer treatment claims.
TRICARE Prior Authorization for Chemotherapy and Targeted Therapy
TMHP Medicaid Oncology Drug J-Code Coverage Denials
Clinical Trial Billing Compliance (UT Health SA Research Protocols)
Radiation Oncology Global Period and Treatment Fraction Billing Errors
Chemotherapy Administration CPT Complexity (96413-96416)
Anti-Cancer Drug HCPCS J-Code Accuracy and Coverage Verification
Concurrent Chemo-Radiation Documentation and Billing Failures
Port Placement and Vascular Access Device Billing Gaps
Why Oncology Billing in San Antonio Requires Specialized Expertise
Oncology billing in San Antonio requires simultaneous expertise in three high-complexity billing environments that rarely coexist in a single market. TRICARE oncology billing requires Defense Health Agency (DHA) prior authorization for each chemotherapy regimen change — including targeted therapy and immunotherapy — with authorization tracking that must align to treatment plan modifications documented by the treating oncologist. The UT Health San Antonio Mays Cancer Center generates clinical trial billing governed by both NCI protocol requirements and individual commercial payer clinical trial coverage policies under the Affordable Care Act’s clinical trial coverage mandate — a billing framework that most oncology billing vendors lack specific expertise in. TMHP Medicaid oncology drug coverage applies Texas-specific formulary restrictions and prior authorization requirements to J-coded antineoplastic drugs that differ from Medicare’s coverage determinations. Bexar County’s Hispanic/Latino cancer demographics also produce distinct ICD-10 coding patterns — cervical (C53.9), hepatocellular (C22.0), and colorectal (C18.9) — where coding specificity directly affects Texas Medicaid and TRICARE medical necessity determinations for treatment authorization.
- TRICARE Standard and Prime chemotherapy authorization management including regimen change tracking and DHA adjudication follow-up for San Antonio military oncology patients
- TMHP Medicaid oncology drug coverage prior authorization and J-code billing under Texas fee schedules and formulary requirements
- Clinical trial billing compliance including routine costs vs trial costs separation, ACA clinical trial coverage mandate application, and NCI protocol documentation
- Chemotherapy administration CPT code selection (96413/96415/96416) based on infusion duration, drug type, and concurrent administration rules
- Anti-cancer drug J-code accuracy and HCPCS coverage verification across TRICARE, TMHP, Medicare, and commercial formularies
- Radiation oncology fraction billing and global period compliance for IMRT (77385/77386), stereotactic radiosurgery, and brachytherapy services
- Port and vascular access device billing (36561/36569) including maintenance and removal CPT codes under TRICARE and commercial payer rules
MedVoice ensures San Antonio oncology practices are fully protected across TRICARE, TMHP, and clinical trial billing frameworks — maximizing oncology revenue cycle performance throughout Bexar County.
Common Diagnoses We Frequently Bill For (ICD-10 Codes)
San Antonio’s oncology ICD-10 coding profile reflects Bexar County’s Hispanic/Latino demographics — with elevated rates of cervical, colorectal, hepatocellular, and gallbladder cancers compared to Texas averages — alongside the full spectrum of solid tumor and hematologic malignancies treated at the UT Health SA Mays Cancer Center.
- Malignant neoplasm of colon, unspecified — C18.9
- Malignant neoplasm of rectum — C20
- Malignant neoplasm of cervix uteri, unspecified — C53.9
- Liver cell carcinoma — C22.0
- Malignant neoplasm of pancreas, unspecified — C25.9
- Malignant neoplasm of prostate — C61
- Malignant neoplasm of upper lobe, bronchus or lung — C34.10
- Malignant neoplasm of unspecified site of left female breast — C50.912
- Diffuse large B-cell lymphoma, unspecified site — C83.30
- Acute myeloblastic leukemia, not achieved remission — C92.00
- Malignant neoplasm of gallbladder — C23
- Malignant neoplasm of bladder, unspecified — C67.9
- Encounter for antineoplastic chemotherapy — Z51.11
- Encounter for antineoplastic radiation therapy — Z51.0
- Malignant (primary) neoplasm, unspecified — C80.1
Common Procedures & Billing Codes We Support
San Antonio oncology practices bill a high volume of chemotherapy infusion, radiation oncology fractions, and surgical oncology procedures — with TRICARE, TMHP, and clinical trial billing each requiring distinct CPT and HCPCS code applications and authorization compliance across the same treatment service lines.
Evaluation & Management
- Office visit, established patient, moderate complexity — 99213
- Office visit, established patient, high complexity — 99214
- Office visit, new patient, high complexity — 99205
- Chemotherapy, intravenous infusion, up to 1 hour — 96413
- Chemotherapy, each additional hour — 96415
- Chemotherapy, highly complex, up to 1 hour — 96416
- Chemotherapy, subcutaneous or intramuscular — 96401
- Therapeutic infusion, initial, up to 1 hour — 96360
- Therapeutic infusion, each additional hour — 96361
- Radiation treatment delivery, IMRT, simple — 77385
- Radiation treatment delivery, IMRT, complex — 77386
- Stereotactic radiosurgery, complete course — 77371
- Tunneled centrally inserted central venous catheter (over 5 years) — 36561
- Tissue examination by pathologist — 88305
Who We Support
Our oncology billing solutions in San Antonio serve the full spectrum of cancer care providers across Bexar County. We also support family practice billing in San Antonio for primary care providers managing cancer screening and survivorship care coordination:
Medical Oncology Practices
Radiation Oncology Centers
Surgical Oncology Groups
TRICARE-Contracted Oncology Clinics
UT Health San Antonio Cancer Center Affiliates
Community Oncology Practices
Hematology-Oncology Groups
Infusion Therapy and Chemotherapy Administration Centers
Compliance & Documentation Accuracy
San Antonio oncology practices operate under a three-layer compliance environment: TRICARE DHA oncology billing regulations, TMHP Medicaid drug coverage and prior authorization standards, and CMS National Coverage Determinations for chemotherapy and radiation oncology services. Clinical trial billing adds NCI protocol compliance and ACA clinical trial coverage mandate requirements. OIG consistently targets oncology billing — particularly drug administration coding, J-code accuracy, and radiation oncology fraction billing — as high-risk areas. MedVoice maintains active compliance monitoring across all applicable frameworks to protect your San Antonio oncology practice.
We ensure compliance with:
- TRICARE (Defense Health Agency) oncology billing regulations for chemotherapy authorization and drug coverage
- Texas Medicaid (TMHP) oncology drug prior authorization and J-code billing requirements
- NCI clinical trial protocol billing standards and ACA clinical trial coverage mandate compliance
- CMS National Coverage Determinations (NCDs) for chemotherapy and radiation oncology services
- OIG high-risk oncology billing areas including drug administration coding and radiation fraction billing
- HIPAA Privacy and Security Rules for oncology patient records, treatment plans, and TRICARE PHI
Benefits of Outsourcing Oncology Billing to MedVoice in San Antonio
San Antonio oncology practices that partner with MedVoice gain a billing team fluent in TRICARE chemotherapy authorization, TMHP drug coverage, and clinical trial billing simultaneously. Our proven oncology billing expertise spans medical oncology, radiation oncology, surgical oncology, and infusion therapy service lines across Bexar County’s complex payer environment.
- 15% increase in revenue collection through TRICARE fee schedule optimization, J-code accuracy, and chemotherapy administration CPT precision
- 40% reduction in A/R days with dedicated TRICARE and TMHP oncology claim follow-up and real-time ERA/EOB posting
- 98% clean claim submission rate through oncology-specific pre-submission scrubbing and J-code coverage verification
- Under 3% denial rate with TRICARE authorization tracking, TMHP drug coverage appeals, and 24-hour resubmission turnaround
- Clinical trial billing compliance including routine vs trial cost separation and ACA coverage mandate application
- Cervical, colorectal, and hepatocellular ICD-10 coding accuracy for Bexar County’s cancer demographics
- Free EHR and Practice Management Software integration for chemotherapy treatment plan and infusion charge capture
- Dedicated San Antonio oncology account manager with TRICARE and TMHP billing expertise from day one
FAQ - Oncology Billing Solutions for Healthcare Practices in San Antonio
How does MedVoice handle TRICARE chemotherapy authorization for San Antonio oncology practices?
MedVoice manages TRICARE DHA prior authorization for each chemotherapy regimen — including initial authorization, regimen change requests when oncologists modify treatment protocols, and authorization extensions for ongoing treatment cycles. We track DHA adjudication timelines and submit clinical documentation supporting medical necessity when TRICARE requests additional information. Our denial management team also handles retroactive TRICARE chemotherapy denials, which most commonly occur when treatment begins before DHA authorization is confirmed.
How does MedVoice manage TMHP Medicaid oncology drug billing in San Antonio?
MedVoice applies TMHP's Texas-specific oncology drug formulary and prior authorization requirements for J-coded antineoplastic agents — verifying coverage status, dosing accuracy against TMHP fee schedules, and prior authorization before each infusion claim is submitted. Texas Medicaid's oncology drug coverage policies differ from Medicare's in several key areas, particularly for targeted therapy and immunotherapy agents, and our TMHP specialists maintain current knowledge of formulary changes that affect San Antonio oncology practices.
How does MedVoice ensure clinical trial billing compliance for UT Health SA affiliates?
Clinical trial billing requires strict separation of routine patient costs (billable to insurance under ACA mandates) from research costs (covered by the trial sponsor). MedVoice implements NCI protocol-specific billing matrices that identify which services are routine vs investigational for each trial, applies correct modifier Q0/Q1 coding for clinical trial claims, and verifies commercial payer clinical trial coverage status — preventing the billing compliance violations that carry significant OIG audit risk for UT Health San Antonio Cancer Center affiliates.
How quickly can a San Antonio oncology practice onboard with MedVoice?
Most San Antonio oncology practices complete MedVoice onboarding in 5-10 business days, including EHR integration with chemotherapy treatment plan and infusion charge capture workflows, TRICARE and TMHP payer setup, and J-code formulary configuration. Practices affiliated with UT Health San Antonio receive dedicated clinical trial billing setup as part of onboarding. You will be assigned a dedicated oncology billing specialist with TRICARE and TMHP expertise from day one.
What makes oncology billing in San Antonio more complex than other Texas markets?
San Antonio oncology practices face a billing environment defined by TRICARE military insurance authorization requirements, TMHP Medicaid drug coverage restrictions, UT Health SA clinical trial billing obligations, and a cancer demographic profile — driven by Bexar County's Hispanic/Latino population — that differs materially from other Texas metros. No other major Texas market combines active military oncology patients, academic clinical trial billing, and a high-Medicaid payer mix at this scale, making specialized San Antonio oncology billing expertise essential for revenue protection on high-cost cancer treatment claims.
Request a Free Oncology Billing Audit Today
MedVoice’s free San Antonio oncology billing audit reviews your TRICARE chemotherapy authorization compliance, TMHP J-code accuracy, clinical trial billing framework, and denial patterns — delivering a concrete revenue recovery roadmap with no obligation. San Antonio oncology practices consistently report measurable reductions in TRICARE and TMHP denial rates, faster reimbursements on high-value infusion claims, and improved net collections within 30 days of onboarding. Partner with the leading oncology medical billing services provider in San Antonio and start protecting your practice revenue today.
